Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Portico™ NG (Next Generation) Transcatheter Aortic Valve in High and Extreme Risk Patients With Symptomatic Severe Aortic Stenosis

NCT04011722 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT04011722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04011722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Portico™ NG (Next Generation) Transcatheter Aortic Valve in High and Extreme Risk Patients With Symptomatic Severe Aortic Stenosis
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 17, 2019
Completion date
January 31, 2033
Enrollment
333 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic severe aortic stenosis